|
Name |
Dehydroxynocardamine
|
Molecular Formula | C27H48N6O8 | |
IUPAC Name* |
1,12-dihydroxy-1,6,12,17,23,28-hexazacyclotritriacontane-2,5,13,16,24,27-hexone
|
|
SMILES |
C1CCNC(=O)CCC(=O)NCCCCCN(C(=O)CCC(=O)NCCCCCN(C(=O)CCC(=O)NCC1)O)O
|
|
InChI |
InChI=1S/C27H48N6O8/c34-22-10-11-23(35)29-18-6-2-8-20-32(40)27(39)15-13-25(37)31-19-7-3-9-21-33(41)26(38)14-12-24(36)30-17-5-1-4-16-28-22/h40-41H,1-21H2,(H,28,34)(H,29,35)(H,30,36)(H,31,37)
|
|
InChIKey |
ABHHIGWFFMCQOC-UHFFFAOYSA-N
|
|
Synonyms |
dehydroxynocardamine; 1,12-dihydroxy-1,6,12,17,23,28-hexazacyclotritriacontane-2,5,13,16,24,27-hexone; 292862-78-3; Terragine E; CHEMBL463548; ACon0_001493; CHEBI:181218; DTXSID301345876; ZINC28539727; NCGC00381071-01!1,12-dihydroxy-1,6,12,17,23,28-hexazacyclotritriacontane-2,5,13,16,24,27-hexone
|
|
CAS | 292862-78-3 | |
PubChem CID | 11606728 | |
ChEMBL ID | CHEMBL463548 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 584.7 | ALogp: | -1.9 |
HBD: | 6 | HBA: | 8 |
Rotatable Bonds: | 0 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 198.0 | Aromatic Rings: | 1 |
Heavy Atoms: | 41 | QED Weighted: | 0.228 |
Caco-2 Permeability: | -5.426 | MDCK Permeability: | 0.00003190 |
Pgp-inhibitor: | 0.013 | Pgp-substrate: | 0.999 |
Human Intestinal Absorption (HIA): | 0.998 | 20% Bioavailability (F20%): | 1 |
30% Bioavailability (F30%): | 1 |
Blood-Brain-Barrier Penetration (BBB): | 0.045 | Plasma Protein Binding (PPB): | 23.37% |
Volume Distribution (VD): | 1.397 | Fu: | 69.14% |
CYP1A2-inhibitor: | 0.001 | CYP1A2-substrate: | 0.041 |
CYP2C19-inhibitor: | 0.042 | CYP2C19-substrate: | 0.035 |
CYP2C9-inhibitor: | 0.101 | CYP2C9-substrate: | 0.785 |
CYP2D6-inhibitor: | 0.029 | CYP2D6-substrate: | 0.055 |
CYP3A4-inhibitor: | 0.111 | CYP3A4-substrate: | 0.007 |
Clearance (CL): | 8.244 | Half-life (T1/2): | 0.26 |
hERG Blockers: | 0.068 | Human Hepatotoxicity (H-HT): | 0.241 |
Drug-inuced Liver Injury (DILI): | 0.017 | AMES Toxicity: | 0.012 |
Rat Oral Acute Toxicity: | 0.863 | Maximum Recommended Daily Dose: | 0.149 |
Skin Sensitization: | 0.157 | Carcinogencity: | 0.001 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.044 |
Respiratory Toxicity: | 0.001 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000942 | 0.841 | D0L5RW | 0.205 | ||||
ENC001146 | 0.224 | D00SBN | 0.182 | ||||
ENC001017 | 0.222 | D04APR | 0.178 | ||||
ENC001147 | 0.214 | D0S5NG | 0.177 | ||||
ENC005563 | 0.203 | D0F9GE | 0.171 | ||||
ENC000840 | 0.200 | D07XVN | 0.168 | ||||
ENC004418 | 0.198 | D0Z8HG | 0.163 | ||||
ENC001527 | 0.196 | D09GFL | 0.161 | ||||
ENC000893 | 0.194 | D07HOB | 0.161 | ||||
ENC005007 | 0.193 | D09ZIO | 0.156 |